CIK 0001671927 · Large accelerated filer
Immunocore Holdings plc
Sign in to watch- Ticker
- IMCR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 01235 5430281
- Business address
- 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom, OX14 4RY
- Former names
- Immunocore Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | Bell John Irving Director | Grant or award · Share Option (Right to Buy) | +27,492 | 27,492 | ||
| 2026-05-27 | Kaul Siddharth Director | Grant or award · Share Option (Right to Buy) | +27,492 | 27,492 | ||
| 2026-05-27 | Herbst Roy Steven Director | Grant or award · Share Option (Right to Buy) | +27,492 | 27,492 | ||
| 2026-05-27 | Ratcliffe Peter John Director | Grant or award · Share Option (Right to Buy) | +27,492 | 27,492 | ||
| 2026-05-27 | Pao William Director | Grant or award · Share Option (Right to Buy) | +27,492 | 27,492 | ||
| 2026-05-27 | Peterson Kristine Director | Grant or award · Share Option (Right to Buy) | +27,492 | 27,492 | ||
| 2026-02-18 | St Leger Tina Amber CHIEF HR OFFICER | Sale | −1,000 | $32.35 | $32K | 1,119 |
| 2026-02-18 | Berman David M HEAD OF R&D | Sale | −5,965 | $32.35 | $193K | 5,859 |
| 2026-02-18 | GOLL JOHN SVP, FINANCE & CAO | Sale | −698 | $32.35 | $23K | 653 |
| 2026-02-18 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Sale | −11,474 | $32.35 | $371K | 12,343 |
| 2026-02-17 | St Leger Tina Amber CHIEF HR OFFICER | Option exercise | +2,119 | 2,119 | ||
| 2026-02-17 | St Leger Tina Amber CHIEF HR OFFICER | Option exercise · Restricted Share Units | −2,119 | 6,357 | ||
| 2026-02-17 | Coy Travis Alan Chief Financial Officer | Grant or award · Restricted Share Units | +33,353 | 33,353 | ||
| 2026-02-17 | Coy Travis Alan Chief Financial Officer | Grant or award · Employee Share Option (Right to Buy) | +95,637 | 95,637 | ||
| 2026-02-17 | Berman David M HEAD OF R&D | Option exercise | +11,824 | 11,824 | ||
| 2026-02-17 | Berman David M HEAD OF R&D | Option exercise · Restricted Share Units | −11,824 | 35,473 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Option exercise | +1,351 | 1,351 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Option exercise · Restricted Share Units | −1,351 | 4,054 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Restricted Share Units | +7,411 | 7,411 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Employee Share Option (Right to Buy) | +21,252 | 21,252 |
Page 1 of 6 · 118 trades